Enviamos información recibida sobre la Pre-publicación del programa de trabajo de Horizon Europe 2025-Cluster Health, Horizonte Europa es el programa marco de investigación e innovación (I+I) de la Unión Europea (UE) para el período 2021 -2027. El objetivo general del programa es alcanzar un impacto científico, tecnológico, económico y social de las inversiones de la UE en I+I, fortaleciendo de esta manera sus bases científicas y tecnológicas y fomentando la competitividad de todos los Estados Miembros (EEMM).
La Comisión Europea acaba de pre-publicar el Programa de Trabajo de Horizonte Europa del Clúster Salud con los siguientes topics:
- Destination – Staying healthy in a rapidly changing society
- HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families
- Destination – Living and working in a health-promoting environment
- HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders
- HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health
- Destination – Tackling diseases and reducing disease burden
- HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
- HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
- HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
- HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
- HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
- HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)
- HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under-researched medical conditions
- HORIZON-HLTH-2025-02-DISEASE-01: European Partnership for Brain Health
- HORIZON-HLTH-2025-02-DISEASE-02: European partnership fostering a European Research Area (ERA) for health research (Phase 2)
- Destination – Ensuring equal access to innovative, sustainable, and high-quality healthcare
- HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)
- Destination – Developing and using new tools, technologies and digital solutions for a healthy society
- HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques
- HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
- HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
- HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies
- Destination – Maintaining an innovative, sustainable, and competitive EU health industry
- HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
- HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices
- HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
Recordamos que se trata de una versión en pre-publicación y se espera la publicación definitiva durante las próximas semanas.
Para más información detallada acerca de los topics, adjuntamos la versión en pre-publicación del Work Programme HE CL1.
Por otro lado, remarcamos otros eventos relacionados de interés:
.
